On Sep 9, 2021 LEXEO Therapeutics closed a Series B round and raised $100,000,000 from Alexandria Venture Investments, CAM Capital, D1 Capital Partners, Eventide Asset […]
Series B – Lycia Therapeutics
On Sep 9, 2021 Lycia Therapeutics closed a Series B round and raised $70,000,000 from Alexandria Venture Investments, Cowen Healthcare Investments, Eli Lilly, Invus, Redmile […]
Series C – Solugen
On Sep 9, 2021 Solugen closed a Series C round and raised $350,000,000 from Baillie Gifford, BlackRock, Carbon Direct, Fifty Years, GIC, Refactor Capital, Temasek […]
Series G – RareCyte
On Sep 9, 2021 RareCyte closed a Series G round and raised $24,000,000 from 5AM Ventures, Agilent Technologies, Arboretum Ventures, F-Prime Capital, HealthQuest Capital, Logos […]
Series A – Neuroglee Therapeutics
On Sep 9, 2021 Neuroglee Therapeutics closed a Series A round and raised $10,000,000 from EDBI, Eisai, Kuldeep Singh Rajput, Openspace Ventures, Raman Singh, Wendou […]
Series D – Mammoth Biosciences
On Sep 9, 2021 Mammoth Biosciences closed a Series D round and raised $150,000,000 from Decheng Capital, Foresite Capital, Greenspring Associates, Mayfield Fund, NFX, Plum […]
Series B – Lycia Therapeutics
On Sep 9, 2021 Lycia Therapeutics closed a Series B round and raised $70,000,000 from Alexandria Venture Investments, Cowen Healthcare Investments, Eli Lilly, Invus, Redmile […]
Series G – RareCyte
On Sep 9, 2021 RareCyte closed a Series G round and raised $24,000,000 from 5AM Ventures, Agilent Technologies, Arboretum Ventures, F-Prime Capital, HealthQuest Capital, Logos […]
HRA Pharma acquired by Perrigo
Sep 8, 2021 Perrigo has entered into an agreement to acquire HRA Pharma in a $2,100,000,000 deal. Perrigo based at Dublin, Dublin, Ireland. “To make […]
Post-IPO Equity – Bluebird Bio
On Sep 8, 2021 Bluebird Bio closed a Post-IPO Equity round and raised $75,000,000 from investors, featuring lead investors . About the company: Bluebird Bio […]